An Assay to Detect Autoantibodies in Human Serum using a Hippocampal Neuronal Culture
JoVE Encyclopedia of Experiments
Immunology
0 views • 3:52 min • July 8th, 2025
Take rat embryo hippocampi.
Add trypsin. Incubate to mediate tissue matrix breakdown, loosening hippocampal cells.
Dilute with a buffer. Incubate for continued enzymatic digestion with trypsin.
Next, transfer the tissue mass to a media-containing tube. Pipette repeatedly for mechanical dissociation into single cells.
Seed cells on poly-L-lysine-coated coverslips within culture plates.
Incubate. Hippocampal cells adhere to the coated surfaces. The neurons develop a lamella and extend minor neurites.
Further, the neurites grow with axonal and dendritic processes, forming a neuronal network.
Mature neurons express synaptic excitatory receptors, N-Methyl -D-aspartate receptors, or NMDARs.
Post-incubation, wash the coverslips with media.
Add a diluted autoimmune encephalitis patient serum. The autoantibodies bind to neuronal NMDARs.
Wash with buffer and then fix the cells.
Add fluorophore-labeled secondary antibodies that bind to the NMDAR-bound autoantibodies.
Wash with buffer. Place the coverslip over mounting media containing DAPI to stain nuclei.
Microscopically observe fluorescence signals on neurons, indicating the presence of autoantibodies in the serum.
For the enzymatic dissociation of the hippocampus at 1 milliliter of 2.5% trypsin in the 50-milliliter tube containing the hippocampi, after bringing the volume in the tube to 5 milliliters with HBSS, incubate the tube for 15 minutes in the water bath at 37 degrees Celsius. To further dilute the trypsin, add 10 milliliters of pre-heated HBSS, and place the tube back in the water bath set at 37 degrees Celsius for 5 minutes.
Next, use a 1,000-microliter micropipette to transfer the hippocampi appearing as a mucous mass to a 50-milliliter tube, and incubate the tissue with 6 milliliters of pre-heated HBSS for 5 minutes, as demonstrated. To dissociate the tissue mechanically, transfer the hippocampal mass to a 2-milliliter tube with conical bottom. After adding 1 milliliter of pre-heated DMEM media, homogenize the pellet with a 1,000-microliter micropipette by gently aspirating up and down.
Ensuring not to create bubbles, repeat the up-and-down aspiration 10 to 20 times with a pre-pulled glass pipette, with its tip in contact with the conical bottom of the tube, until the mixture is translucent. Count the cells before distributing them evenly on a 3.5-centimeter dish with crossed-shaking movements. Once done, place the dish in the incubator with 5% carbon dioxide.
For fluorescent immunostaining of 14 days in-vitro cells, add the sample containing anti-NMDAR antibodies to the coverslips, and incubate at 37 degrees Celsius and 5% carbon dioxide. After one hour, treat the sample with 4% formaldehyde in PBS, as a fixation solution, at room temperature for 5 minutes. Then wash the sample thrice with PBS for 5 minutes each, followed by addition of secondary antibody goat anti-human Alexa Fluor 488 at 1 to 1,000 dilution for 1 hour at room temperature. Next, mount the coverslips containing the sample with a liquid-mounting medium, and aspirate any remaining liquid.
Overview
This article describes a method for isolating and culturing rat embryo hippocampal neurons. The process includes enzymatic and mechanical dissociation of tissue, followed by immunostaining to detect NMDAR autoantibodies.
Key Study Components
Area of Science
- Neuroscience
- Cell Culture
- Immunology
Background
- Hippocampal neurons are crucial for understanding synaptic mechanisms.
- Autoantibodies against NMDARs are implicated in various neurological disorders.
- Isolation of these neurons allows for detailed study of their properties.
- Fluorescent immunostaining is a key technique for visualizing specific proteins.
Purpose of Study
- To develop a reliable method for culturing hippocampal neurons from rat embryos.
- To investigate the binding of autoantibodies to neuronal NMDARs.
- To facilitate further research on the role of NMDARs in neuronal function.
Methods Used
- Enzymatic dissociation of hippocampal tissue using trypsin.
- Mechanical dissociation to obtain single-cell suspensions.
- Seeding cells on poly-L-lysine-coated coverslips for adhesion.
- Fluorescent immunostaining to detect NMDAR autoantibodies.
Main Results
- Successfully isolated and cultured hippocampal neurons.
- Neurons developed axonal and dendritic processes, forming networks.
- Autoantibodies were shown to bind to neuronal NMDARs.
- Fluorescence microscopy confirmed the presence of these autoantibodies.
Conclusions
- The method provides a robust approach for studying hippocampal neurons.
- Findings contribute to understanding the role of NMDARs in neuroimmunology.
- This model can be used for further investigations into neurological diseases.
Frequently Asked Questions
Executive Industry Relevance
Detection of autoantibodies against neuronal surface antigens is critical for early-stage target validation in neuroimmunology drug discovery. This assay enables quantitative assessment of patient-derived autoantibodies binding to NMDARs in a controlled neuronal culture system, supporting mechanistic de-risking and translational biomarker development. Its integration into discovery workflows enhances predictive confidence for portfolio decisions in autoimmune encephalitis and related neurological disorders.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of patient autoantibody binding to neuronal NMDARs for target validation.
- Supports mechanistic de-risking by confirming disease-relevant antibody-antigen interactions in a neuronal context.
- Facilitates triage of candidate targets based on functional antibody engagement.
Screening & Assay Development
- Provides a validated neuronal system for quantitative immunostaining readouts.
- Enables reproducible detection of autoantibody binding for assay standardization.
- Supports downstream screening of patient samples or therapeutic candidates for NMDAR engagement.
Translational & Preclinical Research
- Aligns with translational biomarker strategies by modeling human autoantibody effects in a neuronal system.
- Supports continuity from discovery to preclinical validation of neuroimmune targets.
- Enables risk-adjusted advancement of antibody-targeted therapies based on functional neuronal data.
Pipeline & Workflow Integration
This assay is positioned at the interface of early discovery and translational research, bridging patient sample analysis with preclinical model validation.
- Discovery Biology: Confirms disease-relevant antibody binding to neuronal NMDARs, supporting hypothesis testing and biological de-risking.
- Screening: Delivers quantitative immunofluorescence outputs for reliable comparison of patient and control samples.
- Analytics: Provides measurable fluorescence signals to assess antibody presence and binding intensity.
- Translational Research: Models human autoantibody effects in vitro, supporting biomarker alignment and preclinical continuity.
- Enterprise Reuse: Offers a reusable neuronal culture platform for diverse neuroimmunology research and screening needs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation and reduces mechanistic ambiguity in neuroimmune disorders.
- Operational Value: Standardizes detection of autoantibody binding with reproducible, scalable neuronal assays.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency by focusing on validated neuroimmune targets.
- Portfolio Impact: Enables risk-adjusted prioritization of antibody-targeted programs based on functional neuronal data.
Implementation Considerations
- Requires expertise in neuronal cell culture and immunostaining techniques.
- Needs access to fluorescence microscopy and analytical infrastructure for quantitative readouts.
- Demands cross-team standardization of sample handling and assay protocols.
- Adaptation may be needed for different neuronal subtypes or autoantibody targets.
- Assay sensitivity and specificity depend on neuronal maturity and immunostaining conditions.
Biopharma FAQs
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Related Videos
0 Views
A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
Related Videos
0 Views
Electrochemiluminescence Assays for Human Islet Autoantibodies
Related Videos
0 Views
A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity
Related Videos
0 Views
Isolation and Culture of Hippocampal Neurons from Prenatal Mice
Related Videos
0 Views
A Technique to Culture Mouse Hippocampal Neurons
Related Videos
0 Views
Detection of Protein Palmitoylation in Cultured Hippocampal Neurons by Immunoprecipitation and Acyl-Biotin Exchange (ABE)
Related Videos
0 Views
High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Related Videos
0 Views
The Indirect Neuron-astrocyte Coculture Assay: An In Vitro Set-up for the Detailed Investigation of Neuron-glia Interactions
Related Videos
0 Views
An Optical Assay for Synaptic Vesicle Recycling in Cultured Neurons Overexpressing Presynaptic Proteins
Related Videos
0 Views
Last updated: 22 August 2026